by The Food and Drug Administration (FDA) has recently issued a warning to parents and caregivers regarding several recalled batches of infant formula due to potential bacterial contamination and other health concerns.
According to the pharmaceutical industry, certain batches of Abbott Nutrition’s Similac, Alimentum, and EleCare powdered infant formulas have been recalled due to the presence of Cronobacter sakazakii and Salmonella Newport. These bacteria can cause severe infections, particularly in infants, leading to symptoms such as fever, diarrhea, and vomiting.
Additionally, the FDA has identified other potential risks in the recalled products, including foreign materials, such as metal pieces, and incorrect nutrient levels.
Parents and caregivers are urged to check their supplies of the affected formulas and discontinue use if they have any of the recalled batches. The FDA has provided a list of the affected product codes and lot numbers on its website.
Infants who have consumed the recalled formulas and are experiencing symptoms should seek medical attention immediately. Parents who have questions or concerns about their infant’s formula should contact their healthcare provider or the FDA’s Consumer Complaint Coordinator.
The FDA is working closely with Abbott Nutrition to address the issue and ensure the safety of the affected products. The agency is also conducting a thorough investigation to determine the root cause of the contamination and prevent similar incidents in the future.
Parents are advised to use caution when purchasing and preparing infant formula and to follow proper hygiene practices to minimize the risk of contamination. The FDA recommends preparing formula with clean water and using clean bottles and nipples.
The FDA’s top priority is the safety and well-being of infants and consumers. The agency will continue to provide updates on the investigation and the recall as more information becomes available.
Parents and caregivers are encouraged to stay informed about the recall and to follow the FDA’s guidance to ensure the health and safety of their infants.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it.
